Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization ...

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...

Also in March 2025, Wave announced that the company met with the U.S. Food and Drug Administration (FDA) on WVE-N531 to ...

The marathon legal battle regarding player compensation and the makeup of college athletics in a landmark, ...

REDWOOD CITY, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a ...

Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its first quarter 2025 ...

Novel, oral candidate with first-in-class potential progresses to regulatory non-clinical studies to support a Clinical Trial ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

There’s outrage among chefs and online drama over ‘fake’ or analogue paneer. But experts say the name is the biggest problem.

Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.

Research indicates that consuming a small portion of this delicious fruit can enhance blood circulation to both your heart ...